A detailed history of Yousif Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Yousif Capital Management, LLC holds 665,031 shares of PFE stock, worth $17.1 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
665,031
Previous 672,991 1.18%
Holding current value
$17.1 Million
Previous $18.8 Million 2.2%
% of portfolio
0.21%
Previous 0.22%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$27.7 - $31.39 $220,492 - $249,864
-7,960 Reduced 1.18%
665,031 $19.2 Million
Q2 2024

Jul 31, 2024

SELL
$25.26 - $29.6 $187,429 - $219,632
-7,420 Reduced 1.09%
672,991 $18.8 Million
Q1 2024

Apr 26, 2024

SELL
$25.89 - $29.73 $276,893 - $317,962
-10,695 Reduced 1.55%
680,411 $18.9 Million
Q4 2023

Feb 01, 2024

SELL
$26.13 - $33.94 $720,090 - $935,318
-27,558 Reduced 3.83%
691,106 $19.9 Million
Q3 2023

Oct 30, 2023

SELL
$32.09 - $37.51 $977,814 - $1.14 Million
-30,471 Reduced 4.07%
718,664 $23.8 Million
Q2 2023

Aug 02, 2023

BUY
$36.12 - $41.79 $1.08 Million - $1.25 Million
29,928 Added 4.16%
749,135 $27.5 Million
Q1 2023

May 02, 2023

SELL
$39.39 - $51.28 $1.69 Million - $2.2 Million
-42,951 Reduced 5.64%
719,207 $29.3 Million
Q4 2022

Jan 09, 2023

BUY
$41.75 - $54.5 $804,063 - $1.05 Million
19,259 Added 2.59%
762,158 $0
Q3 2022

Nov 04, 2022

SELL
$43.76 - $53.42 $866,929 - $1.06 Million
-19,811 Reduced 2.6%
742,899 $32.5 Million
Q2 2022

Aug 01, 2022

SELL
$46.53 - $55.17 $1.52 Million - $1.8 Million
-32,660 Reduced 4.11%
762,710 $40 Million
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $39,711 - $49,206
868 Added 0.11%
795,370 $41.2 Million
Q4 2021

Jan 31, 2022

BUY
$41.32 - $61.25 $32.8 Million - $48.7 Million
794,502 New
794,502 $46.9 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.